Guided Therapeutics, Inc.
GTHP
$0.20
-$0.03-12.28%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.10% | -86.81% | -13.46% | -14.10% | -6.22% |
| Total Depreciation and Amortization | -4.00% | 16.67% | 12.50% | 12.50% | 8.70% |
| Total Amortization of Deferred Charges | -28.36% | 44.74% | 145.45% | 277.78% | 109.38% |
| Total Other Non-Cash Items | -710.00% | 2,252.94% | 142.42% | 871.43% | -176.92% |
| Change in Net Operating Assets | -871.43% | 73.82% | 224.64% | -35.76% | -94.02% |
| Cash from Operations | -86.40% | 12.35% | 41.44% | 21.03% | -231.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -37.50% | -66.31% | 77.50% | -- |
| Total Debt Repaid | -47.62% | 5.74% | -50.60% | 48.92% | -219.57% |
| Issuance of Common Stock | 378.05% | -42.62% | -13.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -41.67% | -164.71% | -- |
| Cash from Financing | 1,491.38% | -49.24% | -53.83% | 443.18% | 226.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 212.09% | -112.37% | -20.99% | 141.18% | -86.99% |